PACS

PACS Group, Inc.

NYSE· Services-Skilled Nursing Care Facilities· Inc. DE· CIK 0002001184 Healthcare & Medical Devices

$47.85 −0.91 (−1.87%)

Oct 27 4:00 PM ET · prev $48.76

Market cap

$7.5B

Mid cap

Consensus

Buy

92% Buy or better · 12 analysts

Median target

$59.00

+23% · range $57.00–62.00

Next earnings

Nov 25

in 29 days

1 year

+285.3%

from $12.42 · Oct 28

30 days

+11.1%

from $43.06

52-week range

$10.58–48.76

−2% from high · low Nov 14

Avg volume 20D

827.8K

shares / day

Short interest

4.33M

≈2.7% of shares · +4.8%

Days to cover

5.5

at average volume

Insider net

−$52.1M

since Aug 17 · excl. 3 subscriber-only trades

New fund stakes

Q2 2026 13F · 0 exits

SecBot read BEARISH 6 reports · 90 days

Balance 4 bearish · 0 bullish · 2 neutral oldest → newest, height = score

Avg score

·Next Earnings date, Nov 25, 2026

Strongest BEARISH PACS Group insiders, including CEO Jason Hulse and President Joshua Jergensen, sold a combined $3.57M in…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Mar 5 PACS Group appointed Dr. Patrick Conway, former CMS Deputy Administr…
S Aug 17 to Aug 21 5 days of insider sells: $16.6M by 1 insider, avg $44.11
S Sep 1 to Sep 16 11 days of insider sells: $20.8M by 3 insiders, avg $43.36
S Oct 1 to Oct 21 11 days of insider sells: $14.7M by 2 insiders, avg $45.16

Signal stack

Where each data set points today.

InsidersMIXED

3 insiders sold $52.1M. Excludes 3 subscriber-only trades.
InstitutionsBULLISH

Q2 2026: 30 added (1 new), 12 trimmed or exited. Largest new: Clark Capital Management Group, $11.3M.
AnalystsBULLISH

11 of 12 rate it Buy or better. Every target is above the price.
Short sellersSTEADY

Short interest +4.8% to 4.33M shares. 5.5 days to cover, ≈2.7% of shares.
TrendUPTREND

9% above its 50-day average. New closing high $48.76 on Oct 26.

Who's buying

13F· Q2 2026

new positions

exits

$11.3M

in new stakes

Fund	Move	Shares	Value
AMERICAN CENTURY COMPANIES INC	ADD	3,108,196	$132.5M
AMERIPRISE FINANCIAL INC	ADD	1,995,116	$85.1M
Alyeska Investment Group, L.P.	TRIM	1,539,065	$65.6M
DIMENSIONAL FUND ADVISORS LP	ADD	1,230,728	$52.5M
JANE STREET GROUP, LLC	ADD	583,754	$24.9M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	ADD	428,868	$18.3M
SUSQUEHANNA INTERNATIONAL GROUP, LLP	TRIM	302,319	$12.9M
FIRST TRUST ADVISORS LP	DOUBLED	296,715	$12.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12 analysts

Buy 92% rate it Buy or better

Strong Buy4Buy7Hold1Sell0Strong Sell0

12-month targets · 6 analysts

$47.85 $57.00 $59.00 $62.00

Price is below the lowest target. Median implies +23%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Sep 4, 2026	JP Morgan MAINTAIN	MAINTAIN	Overweight
Aug 10, 2026	Oppenheimer MAINTAIN	MAINTAIN	Outperform
Aug 6, 2026	UBS MAINTAIN	MAINTAIN	Buy
Aug 6, 2026	RBC Capital MAINTAIN	MAINTAIN	Outperform
Aug 6, 2026	Truist Securities MAINTAIN	MAINTAIN	Buy
Jul 8, 2026	UBS MAINTAIN	MAINTAIN	Buy

Insider ledger

Form 4

bought · 0 insiders

$52.1M

sold · 3 insiders · excl. 3 subscriber-only trades

Date	Insider	Type	Value
Oct 23, 2026	🔒 Fresh data, subscribers only	SELL
Oct 23, 2026	🔒 Fresh data, subscribers only	SELL
Oct 22, 2026	🔒 Fresh data, subscribers only	SELL
Oct 21, 2026	Murray Jason Hulse Co-Founder, CEO & Chairman	SELL	$314.8K
Oct 20, 2026	Murray Jason Hulse Co-Founder, CEO & Chairman	SELL	$1.8M
Oct 19, 2026	Murray Jason Hulse Co-Founder, CEO & Chairman	SELL	$77.1K
Oct 16, 2026	Murray Jason Hulse Co-Founder, CEO & Chairman	SELL	$402.9K
Oct 15, 2026	Murray Jason Hulse Co-Founder, CEO & Chairman	SELL	$211.3K

Earnings setup

Estimates

Nov 25

reports in 29 days

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only